Image

Global E-Pharma Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global E-Pharma Market, By Application (Hospitals, Personal Use, Government Research), Type (Pharmacy Benefit Manager, Legitimate Internet Pharmacy, Illegal or Unethical Internet Pharmacy), Product Types (Generic, Branded) – Industry Trends and Forecast to 2029.

E-Pharma Market

E-Pharma Market Analysis and Size

In general, there are three types of e-pharmacies available on the market, organized e-pharmacies, non-organized e-pharmacies, and e-pharmacies used for illegal international commerce. The general public benefits from e-pharmacy in a number of ways, including customer convenience, access, education, data records, and medicine legitimacy.

Data Bridge Market Research analyses that the e-pharma market which was USD 42768.85 million in 2021, would rocket up to USD 180734.73 million by 2029, and is expected to undergo a CAGR of 19.74% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

E-Pharma Market Scope and Segmentation      

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Application (Hospitals, Personal Use, Government Research), Type (Pharmacy Benefit Manager, Legitimate Internet Pharmacy, Illegal or Unethical Internet Pharmacy), Product Types (Generic, Branded)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Boehringer Ingelheim International GmbH (Germany), AbbVie Inc (U.S.), Aurobindo Pharma (India), Pfizer Inc. (U.S.), Walmart Inc. (U.S.), Walgreen Co. (U.S.), Express Scripts (U.S.), The Kroger Co. (U.S.), L Rowland & Co (U.K.), DocMorris (Germany), Giant Eagle, Inc. (U.S.), OptumRx, Inc. (U.S.), CVS Health (U.S.), Merck & Co., Inc. (U.S.) and Thermo Fisher Scientific Inc. (U.S.)

Market Opportunities

  •  Increasing aging population
  • Expansion of the distribution network for online pharmacies

Market Definition

The definition of the "e-Pharma market" is the mode of exchange between pharmacies and pharmaceutical firms. One of the most recent inventions that has emerged as the most practical means to order medications is the e-pharma industry.

E-Pharma Market Dynamics

Drivers

  • Increasing government initiatives

Rising emerging technologies like artificial intelligence (AI) and machine learning (ML) help in ensuring customer satisfaction by recommendation engines, increasing internet penetration due to cheap data rate, rising government initiatives, changing regulations, increasing internet penetration in urban as well as rural areas, and rising prevalence for e-prescriptions are all key factors escalating the market growth.

  • Rising research and development activities

Additionally, rising emerging markets with an increasing geriatric population base, rising research and development activities in the healthcare sector, and rising technological advancements and modernization in the healthcare sector will further create new opportunities for the E-pharma market in the anticipated period of 2022–2029.

  • Rise in the geriatric population

The rising prevalence rates of lifestyle disorders like as diabetes and obesity, rising health-care spending, and the fast-growing diagnostic industry are driving the worldwide e-pharma market expansion. In addition, the growing elderly population, increased demand for laboratory automation, and more awareness of preventative healthcare are all driving the E-pharma market forward.

Opportunities

The pharmaceutical industry's expanding use of e-commerce platforms is now fuelling market expansion. Additionally, the market expansion is being fuelled by expanding internet connectivity and the widespread use of smart gadgets.

Restraints/Challenges

However, the market would be constrained by an increase in illicit online pharmacies and the availability of bogus medications online, which will further hinder the growth of the e-pharma industry throughout the forecast period.

This e-pharma market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the e-pharma market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on E-Pharma Market

Additionally, an increasing variety of in-app features, like special discounts, personalised purchases, expedited delivery, etc., are supporting the global market expansion. As a result of the rapid COVID-19 epidemic, brick-and-mortar pharmacies are gradually giving way to online pharmacy platforms in an effort to reduce the danger of coronavirus infection through human contact. Predictive analytics, artificial intelligence (AI), health information technology (HIT), and other cutting-edge technologies will increasingly be combined with e-pharmacy solutions to drive the global market in the years to come.

Global E-Pharma Market Scope

The e-pharma market is segmented on the basis of product type, application and type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

  • Hospitals
  • Personal Use
  • Government Research

Type

  • Pharmacy Benefit Manager
  • Legitimate Internet Pharmacy
  • Illegal or Unethical Internet Pharmacy

Product Types

E-Pharma Market Regional Analysis/Insights

The e-pharma market is analysed and market size insights and trends are provided by country, product type, application and type as referenced above.

The countries covered in the e-pharma market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the e-pharma market due to rise in the number of patients due to unhealthy lifestyle, rising government initiatives, changing regulations, and increasing internet penetration in urban as well as rural areas in this region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to rising aging population and rising government initiatives in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and E-Pharma Market Share Analysis

The e-pharma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to e-pharma market.

Some of the major players operating in the e-pharma market are:

  • Boehringer Ingelheim International GmbH (Germany)
  • AbbVie Inc (U.S.)
  • Aurobindo Pharma (India)
  • Pfizer Inc. (U.S.)
  • Walmart Inc. (U.S.)
  • Walgreen Co. (U.S.)
  • Express Scripts (U.S.)
  • The Kroger Co. (U.S.)
  • L Rowland & Co (U.K.)
  • DocMorris (Germany)
  • Giant Eagle, Inc. (U.S.)
  • OptumRx, Inc. (U.S.)
  • CVS Health (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)

Research Methodology: Global E-Pharma Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The e-pharma market value is projected at USD 180734.73 million by 2029.
The e-pharma market is projected to grow at a CAGR of 19.74% during the forecast period of 2022-2029.
On the basis of application, the E-Pharma Market is segmented into Hospitals, Personal Use, Government Research.
The major players operating in the E-Pharma Market are Boehringer Ingelheim International GmbH (Germany), AbbVie Inc (U.S.), Aurobindo Pharma (India), Pfizer Inc. (U.S.), Walmart Inc. (U.S.), Walgreen Co. (U.S.), Express Scripts (U.S.), The Kroger Co. (U.S.), L Rowland & Co (U.K.), DocMorris (Germany), Giant Eagle, Inc. (U.S.), OptumRx, Inc. (U.S.), CVS Health (U.S.), Merck & Co., Inc. (U.S.) and Thermo Fisher Scientific Inc. (U.S.).